Search - Supreme Court of the United States

Docket for 21-1566

	Search documents in this case:
No. 21-1566
Title:	Juno Therapeutics, Inc., et al., Petitioners v. Kite Pharma, Inc.
Docketed:	June 15, 2022
Linked with 21A461
Lower Ct:	United States Court of Appeals for the Federal Circuit
Case Numbers:	(2020-1758)
Decision Date:	August 26, 2021
Rehearing Denied:	January 14, 2022
Discretionary Court Decision Date:

Date	Proceedings and Orders
Feb 25 2022	Application (21A461) to extend the time to file a petition for a writ of certiorari from April 14, 2022 to June 13, 2022, submitted to The Chief Justice.
	Main Document Lower Court Orders/Opinions Lower Court Orders/Opinions Lower Court Orders/Opinions Proof of Service
Mar 07 2022	Application (21A461) granted by The Chief Justice extending the time to file until June 13, 2022.

Jun 13 2022	Petition for a writ of certiorari filed. (Response due July 15, 2022)
	Petition Appendix Appendix Certificate of Word Count Proof of Service
Jun 28 2022	Motion to extend the time to file a response from July 15, 2022 to August 24, 2022, submitted to The Clerk.
	Main Document
Jun 29 2022	Motion to extend the time to file a response is granted and the time is extended to and including August 24, 2022.

Jul 15 2022	Brief amicus curiae of City of Hope filed.
	Main Document Proof of Service Certificate of Word Count
Jul 15 2022	Brief amici curiae of Mark D. Janis and Timothy R. Holbrook filed.
	Main Document Certificate of Word Count Proof of Service
Jul 15 2022	Brief amicus curiae of REGENXBIO Inc. filed.
	Main Document Proof of Service Certificate of Word Count
Jul 15 2022	Brief amici curiae of Amgen Inc., et al. filed.
	Main Document Proof of Service Certificate of Word Count
Jul 15 2022	Brief amici curiae of St. Jude Children’s Research Hospital, Inc., et al. filed.
	Main Document Proof of Service Certificate of Word Count
Aug 24 2022	Brief of respondent Kite Pharma, Inc. in opposition filed.
	Main Document Proof of Service Certificate of Word Count
Sep 07 2022	DISTRIBUTED for Conference of 9/28/2022.

Sep 07 2022	Reply of petitioners Juno Therapeutics, Inc., et al. filed. (Distributed)
	Main Document Proof of Service Certificate of Word Count
Oct 03 2022	DISTRIBUTED for Conference of 10/7/2022.

Oct 11 2022	DISTRIBUTED for Conference of 10/14/2022.

Oct 24 2022	DISTRIBUTED for Conference of 10/28/2022.

Oct 31 2022	DISTRIBUTED for Conference of 11/4/2022.

Nov 07 2022	Petition DENIED.

Nov 23 2022	Petition for Rehearing filed.
	Main Document Certificate of Word Count Proof of Service
Dec 07 2022	DISTRIBUTED for Conference of 1/6/2023.

Jan 09 2023	Rehearing DENIED.

NAME	ADDRESS	PHONE
Attorneys for Petitioners
Gregory Andrew Castanias Counsel of Record	Jones Day 51 Louisiana Ave., NW Washington, DC 20001 gcastanias@jonesday.com	(202) 879-3939
Party name: Juno Therapeutics, Inc., et al.
Attorneys for Respondent
E. Joshua Rosenkranz Counsel of Record	Orrick, Herrington & Sutcliffe LLP 51 West 52nd Street New York, NY 10019 jrosenkranz@orrick.com	212-506-5380
Party name: Kite Pharma, Inc.
Other
Matthew James Dowd Counsel of Record	Dowd Scheffel PLLC 1717 Pennsylvania Avenue, NW Suite 1025 Washington, DC 20006 mdowd@dowdscheffel.com	202-559-9175
Party name: REGENXBIO Inc.
Daralyn Jeannine Durie Counsel of Record	Durie Tangri LLP 217 Leidesdorff St San Francisco, CA 94111 ddurie@durietangri.com	415-362-6666
Party name: City of Hope
Timothy R. Holbrook Counsel of Record	Emory University School of Law 1301 Clifton Rd, NE Atlanta, GA 30322 tholbrook@emory.edu	404-712-0353
Party name: Mark D. Janis and Timothy R. Holbrook
Jeffrey Alan Lamken Counsel of Record	MoloLamken LLP The Watergate, Suite 500 600 New Hampshire Ave., N.W. Washington, DC 20037 jlamken@mololamken.com	2025562010
Party name: Amgen Inc., Association of University Technology Managers (AUTM), Instil Bio, Inc., Corning Incorporated, Bavarian Nordic A/S, and GlaxoSmithKline plc
Vanessa Y. Yen Counsel of Record	King & Spalding LLP 1185 Ave. of the Americas, 34th Floor New York, NY 10036 vyen@kslaw.com	(212) 556-2100
Party name: St. Jude Children’s Research Hospital, Inc., Albert Einstein College of Medicine, the University of Texas MD Anderson Cancer Center, and Other Academic Research Institutions